Johnson & Johnson opens Boston Innovation Center

Friday, June 28, 2013 02:12 PM

Johnson & Johnson have announced the opening of the Johnson & Johnson Innovation Center in Boston. As part of Johnson & Johnson Innovation, the goal of the Boston Innovation Center is to advance healthcare by catalyzing collaborations in science and technology between regional innovators and the Johnson & Johnson family of companies across a diverse spectrum of early-stage opportunities.

The Boston Innovation Center is home to a team of business, science and transaction experts who are focused on identifying and building novel early-stage collaborations with emerging companies, entrepreneurs and academic centers across eastern North America. This team has full and broad deal-making capabilities, with flexibility to adapt deal structures to match early-stage needs and opportunities.

"With the establishment of our Boston Innovation Center, we look forward to further fostering collaboration with some of the world's leading scientists, renowned academic centers and influential entrepreneurs to enable future innovations that will advance human health,” said Paul Stoffels, M.D., Johnson & Johnson chief scientific officer and worldwide chairman, pharmaceuticals.

The Boston Innovation Center's first collaborations and new initiatives include a research alliance with The Icahn School of Medicine at Mount Sinai to advance the scientific understanding of inflammatory bowel disease (IBD) and the discovery of next generation therapeutic solutions; a collaboration with Rodin Therapeutics, a biotechnology company focused on applying insights of epigenetics, to advance novel therapeutics for neurological disorders such as Alzheimer's disease; a collaboration with Vedanta to advance a novel class of therapies that modulate pathways of interaction between the human microbiome and the host immune system; and the establishment of Janssen Labs at the LabCentral facility in the Kendall Square biotech hub.

Johnson & Johnson opened an innovation center in London in March, one in California in early June, and plans to open one in Shanghai by the end of the year.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs